SOLV

Solventum Corporation

HealthcareMedical Instruments & SuppliesNASDAQ

$74.95

-$1.76 (-2.35%)today

Conviction

6/ 10

Fair Value$86.58

Upside+15.52%

Signal9.31

Market Cap$10.9B

52W Range$60.70–$88.20

Next EarningsMay 7

Conviction History

Conviction Changes

Mar 19, 2026, 1:07 AM5→6conviction-rescore

Premium Content

Upgrade to premium to see the full reasoning behind each conviction change.

Price History

FAIR VALUE ANALYSISMonte Carlo · 5,000 runs · 99% valid

Fair Value$79.51

Current Price$65.78

Upside / Down+20.9%

P(Undervalued)72.3%

P(20%+ Up)50.9%

P(15%+ Down)14.8%

Fair Value Distribution — percentile bands

72.3% of simulations place fair value above current price

WHAT IS PRICED IN

Revenue-Based Reverse DCF

-1.7%/yr

±5.3% · revenue growth to justify current price

FCF-Based Reverse DCF

0.5%/yr

±2.6% · FCF growth to justify current price

THE GAP

Market pricing margin compression or rising capex

Premium Content

Upgrade to premium for full distribution data, sensitivity analysis, and segment breakdowns.

Bull Case

No analysis yet

Bear Case

No analysis yet

Research Feed

sec_10kMar 4

Conviction: unchanged

SOLV 10-K 2025: Post-Spin Healthcare Leader with Scale & Execution Risk

SOLV is a newly spun healthcare company with diversified exposure to wound care, dental, and health IT. Strong heritage post-3M, but faces execution risks on independence, 3M dependency tail risks, an...